Vaccines, blood, antisera, toxins and cultures in   Cayman Islands

Exports In 2022, Cayman Islands exported $6.06k in Vaccines, blood, antisera, toxins and cultures, making it the 169th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 165th most exported product in Cayman Islands. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Cayman Islands are: Bermuda ($2.85k), Bahamas ($976), Estonia ($896), Trinidad and Tobago ($620), and Austria ($596).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Cayman Islands between 2021 and 2022 were Bermuda ($2.85k), Bahamas ($976), and Estonia ($896).

Imports In 2022, Cayman Islands imported $3.6M in Vaccines, blood, antisera, toxins and cultures, becoming the 175th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 74th most imported product in Cayman Islands. Cayman Islands imports Vaccines, blood, antisera, toxins and cultures primarily from: United Kingdom ($1.94M), Germany ($407k), Costa Rica ($322k), India ($321k), and United States ($263k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Cayman Islands between 2021 and 2022 were India ($174k), South Korea ($47.1k), and Belgium ($25.7k).